!donald

papermori asked:

It's so hard to get the cats in the new pose! The one with their heads down!

I knoooooow! My theory is that they only do it for a really short amount of time and only if they do the normal sleeping cat loaf pose first, they fall over for a few minutes and then go back to the original pose, so it’s hard to catch them doing it! That’s at least what I noticed

-stef

thephandemonium asked:

For the anon questioning their sexuality at 13, I was in the same spot when I was 12, if I'm not wrong. It's alright, friend. Your age doesn't make the thoughts in your head any less valid (no matter what they are). I can't say that everyone will be open and be like "You're questioning? That's okay!" but there will be people who'll get it. I get it. If you want to talk, you could message me on or off anon but yeah, you've got most of us here to help. You'll be okay :))

^^^

Judo, Grand Slam de Paris. Sofiane Milous: "Paris me porte la poisse"

Le judoka d'Argenteuil revient sur son élimination en 8e de finale.


Le Grand Slam de Paris devait permettre à Sofiane Milous de se relancer dans la course olympique. Mais le numéro 2 français des - 60 kg, battu par l'Allemand Tobias Englmaier en 8e de finale, n'a pas réussi à bousculer la hiérarchie dans un catégorie dominée par Vincent Limare (Maisons-Alfort), lui-même éliminé au même stade de la compétition.
On peut considérer que c'est une mauvaise journée pour vous ?
SOFIANE MILOUS. Ce n'est que du sport. Mais oui… J'avais tout pour aller au bout. Physiquement, je me sentais bien alors que je sors d'une fracture au pied gauche et que j'ai dû me préparer à fond en une semaine seulement. J'ai réussi à faire des super matchs. Je gagne au 2e tour face au champion du monde 2014 (le mongol Boldbaatar Ganbat) mais je perds de peu devant l'Allemand. C'est frustrant. C'était ma quatrième participation à ce tournoi, et à chaque fois… Paris me porte la poisse (5e en 2010 et 2013, 7e en 2015). Mais je ne baisse pas les bras pour autant.
Votre élimination prématurée vous laisse toujours en retrait dans la course à la qualification olympique ?
Oui mais j'ai montré de belles choses. Je reste confiant. Je n'ai pas fait autant de sacrifices pendant des années pour que mon palmarès ne se résume qu'à un titre de champion d'Europe (en 2010).
Vous vous voyez encore aux Jeux de Rio ?
J'y pense toujours. J'ai été champion d'Europe à 21 ans en battant les meilleurs. J'ai aujourd'hui le bon âge (27 ans) pour aller décrocher les plus belles médailles

Retrouvez cet article sur LeParisien.fr

Evian TG-Paris FC (1-0) : le calvaire continue…
Football, Ligue 2 : le Paris FC poursuit son chemin de croix après sa défaite (1-0) à Evian TG
Ligue 2 : renversant Red Star à Sochaux (1-2) !
Football, Ligue 2: Creteil ne lâche pas prise à Valenciennes (2-2)
Judo, Grand Slam de Paris: Buchard forfait pour un problème de poids !
Quick Heal IPO to hit markets on Feb 8: 10 key points to know before subscribing

Quick Heal Technologies Limited is going to hit the capital markets with its initial public offerings (IPO) on February 8, 2016. ICICI Securities Limited, Jefferies India Private Limited, and JP Morgan India Private Limited are the book running lead managers for the issue.

Here are 10 key takeaways you should know about Quick Heal before investing in the public offer: 

About the company: Quick Heal is one of the leading providers of security software products and solutions in India with a market share of over 30 per cent in the retail segment according to the Zinnov Industry Report. The company’s end customers include home users, small offices and home offices, enterprises, educational institutions, as well as government agencies and departments.

About the offer: The IPO consists of a fresh issue of Rs 2,500 million by the company and an offer for sale of upto 6,269,558 equity shares by promoters Kailash Sahebrao Katkar and Sanjay Sahebrao Katkar, apart from Sequoia Capital India Investment Holdings III and Sequoia Capital India Investments III. The IPO will close on February 10.

Price Band: The company has set a price band of Rs 311 to Rs 321 per equity share of face value of Rs 10 each.

Objective of the issue: While the proceeds from the offer of sale would not go to Quick Heal Technologies, the Rs 250 crore funds raised from fresh issue of equity shares would be used by the company for advertising and sales promotion and capital expenditure for research and development. The proceeds would also be invested to purchase, develop and renovate its office premises in Kolkata, Pune and New Delhi, as well as general corporate needs.

Financials: For the financial year ended March 2015, Quick Heal generated total revenue of Rs 2,94.34 crore, gross profit of Rs 2,60.62 crore, EBITDA of Rs 91.80 crore and restated profit for the year of Rs 53.80 crore. For the five fiscal years ended March 2015, the company’s total revenue, gross profit, EBITDA and restated profit grew at a CAGR of 21.94 per cent, 20.97 per cent, 13.07 per cent and 8.67 per cent, respectively.

For the financial year ended 2015, Quick Heal derived 97.31 per cent and 2.69 per cent of its revenue from sales to users within India and outside India, respectively.

Headcounts: As of June 30, 2015, we had 1,231 full-time employees, including 449 employees in the R&D team and 345 employees in our Sales & Marketing team.

Listing: Quick Heal’s equity shares are proposed to be listed on the BSE and the NSE.

Outlook: According to SMC Investment and Advisors, Quick Heal enjoys preferred anti-virus solution provider company status with a market share of 30 per cent in the domestic market. It hopes to increase its substantially as its products have been receiving approval from world renowned agencies. In the RHP, there are no listed peers to compare with and thus this issue is also from the first mover of the segment and may create fancy, but it cannot be denied that the issue price looks expensive. An investor can opt the issue for long term investment.

Valuation: According to SMC, considering the P/E valuation on the upper end of the price band of Rs 321, the stock is priced at pre issue P/E of 41.24x on its FY16 EPS of Rs 7.78. Post issue, the stock is priced at a P/E of 46.41 x on its EPS of Rs 6.92. Looking at the P/B ratio at Rs 321 the stock is priced at P/B ratio of 5.26x on the pre issue book value of Rs 61.06 and on the post issue book value of Rs 89.96 the P/B comes out to 3.57x.